Clinical Trial Update: L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for L-BLP25 in colorectal cancer patients after hepatic metastases resection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Carcinoma
• Rectal Carcinoma

Drugs mentioned

• L-BLP25

Snippet

Sponsor: Prof. Dr. Carl Schimanski | Conditions: Colon Carcinoma, Rectum Carcinoma | Phase 2 | Status: COMPLETED